Atlas Trials

Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer

Clinical trial NCT00126568 · TERMINATED

Trial details

NCT number
NCT00126568
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Anaplastic Thyroid CancerRecurrent Thyroid Cancer
Start date
2005-06-01
Primary completion
2011-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.